Document Detail


Effect of human leukocyte antigen class II genes on insulin deficiency in slow-onset type 1 diabetes in the Japanese population.
MedLine Citation:
PMID:  21497933     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The aim of this study is to determine the contribution of human leukocyte antigen (HLA) class II genes to insulin deficiency in slow-onset type 1 diabetes (T1D). Our results suggest that the susceptibility conferred by HLA subtypes to slow-onset T1D differs between insulin-deficient patients and non-insulin-deficient patients.
Authors:
Masahito Katahira; Mizuki Hanakita; Yoshinori Yasuda; Harumi Maeda; Tatsuo Ito; Satoko Segawa
Related Documents :
6680543 - Diabetes in tropics--perspectives of research.
21298413 - Receptor for advanced glycation end-products (rage) provides a link between genetic sus...
14749263 - Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (apm...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-15
Journal Detail:
Title:  Diabetes research and clinical practice     Volume:  -     ISSN:  1872-8227     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8508335     Medline TA:  Diabetes Res Clin Pract     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Endocrinology and Diabetes, Ichinomiya Municipal Hospital, 2-2-22 Bunkyo, Ichinomiya, Aichi 491-8558, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Environmental factors influencing the inactivation of Cronobacter sakazakii by high hydrostatic pres...
Next Document:  Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome.